info@skinbiotherapeutics.com | +44 161 468 2760

SkinBioTherapeutic
SkinBioTherapeutic
Menu
  • Home
  • Technology
  • Applications
  • Sectors
  • About us
  • Team
  • News & Articles
  • Investor Relations
  • Contact us
Presentations

Stuart Ashman Discusses Winclove – AxisBiotix® Agreement

5th May 2020 9:57 am6th May 2020
Previous ArticleStuart Ashman CEO at AJ Bell Investor EveningNext ArticleStuart Ashman Discusses Croda PLC – SkinBiotix® Agreement

About us

The microbiome is the genetic material of all the microbes – bacteria, fungi, protozoa and viruses – that live on and inside the human body. The microbiome has essential beneficial functions relevant to supporting life and it is a fundamental component of human physiology.

Articles

  • SkinBioTherapeutics assessing options for a ‘rapid trial’ of its food supplement
  • Stuart Ashman presenting at the ShareProphets Virtual Show on Saturday 9th May 2020
  • Stuart Ashman Discusses Croda PLC – SkinBiotix® Agreement

Links

  • Home
  • Technology
  • Applications
  • Sectors
  • About us
  • Team
  • News & articles
  • Investor Relations
  • Contact us
  • Privacy Policy

Contact

SkinBioTherapeutics PLC
15 Silk House
Park Green
Macclesfield
SK11 7QJ

+44 161 468 2760

© 2017-2020 SkinBioTherapeutics PLC | All Rights Reserved

Menu
  • Home
  • Technology
  • Applications
  • Sectors
  • About us
  • Team
  • News & Articles
  • Investor Relations
  • Contact us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy